syriQ® Ready-to-use prefillable glass syringes for vaccines
Request quotesyriQ®: Prefillable glass syringes for vaccines
As the pharmaceutical industry continues to shift from traditional vials to prefillable syringes, ensuring vaccine integrity throughout storage, transport, and administration has become increasingly critical.
Made from high-quality FIOLAX® Type I Borosilicate Glass, SCHOTT Pharma’s syriQ® prefillable glass syringes for vaccines provide a reliable, ready-to-use solution that minimizes manual preparation steps while enhancing safety, efficiency, and vaccine shelf life.
Improved by continuous development and complemented by the SCHOTT iQ® platform for efficient fill-and-finish processing, syriQ® is a trusted choice for both traditional and emerging drug technologies, from inactivated vaccines to breakthrough mRNA solutions.
Proven safety, reliable performance, and ready-to-use efficiency for vaccines
Made from FIOLAX® Type I Borosilicate Glass, syriQ® prefillable glass syringes offer stable storage and extended vaccine shelf life.
Tight dimensional tolerances ensure accurate filling and reliable functionality, while proven container closure integrity is maintained for both standard and emerging drug models, even in demanding conditions down to -50 °C.
Reliable drug delivery across different vaccine types
syriQ® prefillable syringes are ideal for the storage and administration of a wide variety of vaccines, including inactivated vaccines such as the flu shot, live-attenuated vaccines such as the MMR vaccine, subunit and recombinant vaccines such as HPV vaccines, and even breakthrough mRNA vaccines.
In addition, syriQ® prefillable glass syringes for vaccines can be used for diluent applications and support an efficient fill-and-finish process.
|
|
|
|
| Product Name |
Product Name
syriQ®
|
Product Name
syriQ BioPure®
|
Product Name
syriQ BioPure® silicone-free
|
| Applications |
Applications
Variety of vaccines, including inactivated (flu shot), live-attenuated (MMR), subunit and recombinant vaccines (HPV) and breakthrough mRNA vaccines, diluent applications
|
Applications
Biologics, Large-volume drugs
|
Applications
Silicone-sensitive biologics
|
| Tubing Container Material |
Tubing Container Material
FIOLAX® Type I Borosilicate Glass
|
Tubing Container Material
FIOLAX® Type I (CHR**) Borosilicate Glass
|
Tubing Container Material
FIOLAX® Type I CHR** Borosilicate Glass
|
| Format |
Format
0.5 - 3 ml
|
Format
1 ml lg staked needle, 2.25 ml staked needle, 5.5 ml staked needle
|
Format
1 ml staked needle, 2.25 ml staked needle upon request
|
| Closure Systems |
Closure Systems
syriQ® Rigid Cap (SRC) or OVS®*
|
Closure Systems
Rigid Needle Shield (RNS)
|
Closure Systems
Rigid Needle Shield (RNS)
|
| Pre-washed, Pre-sterilized |
Pre-washed, Pre-sterilized
RTU
|
Pre-washed, Pre-sterilized
RTU
|
Pre-washed, Pre-sterilized
RTU
|
| Packaging |
Packaging
Pre-sterilized syringes in tub- and nest-configuration
|
Packaging
Pre-sterilized syringes in tub- and nest-configuration
|
Packaging
Pre-sterilized syringes in tub- and nest-configuration
|
| Read More | Read More |
* OVS® is a registered trademark of Vetter-Pharma International GmbH, Germany
** Controlled hydrolytic resistance (CHR)
Get in touch
Dr. Sven Pohle